Written and Visual Messages on Sanitary Nap Packagig
Launched by ONDOKUZ MAYIS UNIVERSITY · May 31, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how written and visual messages on sanitary napkin packaging can impact women's knowledge and attitudes towards family planning. Researchers believe that just like cigarette packages contain health warnings, adding helpful information about family planning on sanitary pad packages could make a difference in how women think about and use contraception. The study will take place in Samsun, Turkey, and will involve women visiting Family Health Centers with babies aged 9 to 18 months.
To participate, women must be at least primary school graduates, married, have an active sexual life, and not currently using modern family planning methods. Participants will be divided into two groups: one will receive specially designed sanitary napkin packages with family planning information, while the other group will not receive any additional materials. Over the course of the study, participants will answer questions about their knowledge and attitudes towards family planning at two different times. This trial aims to gather valuable information that could help improve family planning education for women.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women who are at least primary school graduates,
- • Those who have a baby aged 9-18 months,
- • Those who do not use AP methods or traditional AP methods (withdrawal, Calendar method),
- • Those who are married and have a sexual partner,
- • Those who have an active sexual life,
- • Those who have a regular menstrual cycle,
- • Those who do not have any obstacles that prevent communication,
- • Those who are willing to give their phone number,
- • Those who use a smartphone,
- • Women who are at least primary school graduates will be included.
- Exclusion Criteria:
- • Those who received family planning training in the postpartum period,
- • Those who use modern FP methods,
- • Those who underwent hysterectomy surgery due to complications such as bleeding in the postpartum period,
- • Those who have a history of infertility and became pregnant with assisted reproductive techniques,
- • Those who have any health problems (such as thyroid, cancer) that negatively affect the menstrual cycle,
- • Those who have any chronic diseases (such as cancer, diabetes, hypertension, hypercholesterolemia, heart disease, etc.) or use of medications (such as diuretics, antihypertensives, antihistamines, anticholinergics, etc.) that negatively affect sexual health,
- • Those who are pregnant or planning to get pregnant again,
- • Women who do not agree to participate in the study or who give up participating in the study or provide incorrect or incomplete information will not be included in the study.
About Ondokuz Mayıs University
Ondokuz Mayıs University is a prestigious academic institution located in Turkey, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its cutting-edge facilities and a multidisciplinary team of experts to conduct innovative studies that aim to enhance patient care and contribute to scientific knowledge. With a focus on ethical standards and rigorous methodologies, Ondokuz Mayıs University is dedicated to fostering collaborations that drive breakthroughs in healthcare, ultimately improving treatment outcomes and patient well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Samsun, , Turkey
Patients applied
Trial Officials
Yasemin Sökmen, Asist prof
Study Director
OndokuzMU
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported